VTAK - Catheter Precision Enterprise Value

The price evolution of Catheter Precision (VTAK) on the GURU.Markets platform demonstrates an Enterprise Value of 15.07. The brand is gaining recognition among cardiologists due to its advanced mapping for the treatment of rhythm disorders. The business's uniqueness lies in creating 3D pathology models using MRI, which optimizes surgical operations. Financial stability is based on the regular supply of diagnostic complexes to medical centers.

VTAK Catheter Precision Inc: Enterprise Value in the range 11/23/2025 - 10/05/2026

Catheter Precision (VTAK) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Catheter Precision Inc|VTAK - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Catheter Precision|VTAK - Total Company Value
- book capitalization data:
Book Value per Share Catheter Precision|VTAK - Book Capitalization|Market Value to Book Value catheterprecision.com|VTAK - Company Total Assets
- debt and liquidity data:
Debt to Capital Catheter Precision|VTAK - Long-Term Debt to Capital|Short-Term Debt to Capital catheterprecision.com|VTAK - Company Debts|Debt to Net Assets Ratio Catheter Precision
Comprehensive company analysis:VTAK - Catheter Precision Inc

The high macro-resilience of Catheter Precision (VTAK) arrhythmia treatment equipment makes the enterprise value (EV) a reliable indicator of the asset's fundamental value. By summing the market capitalization and debt minus cash, this metric determines the actual cost of a full buyout of the company, allowing investors to objectively assess the enterprise value without market distortions.

Competitors of Catheter Precision

Aggregate Business Value Regeneron Pharmaceuticals, Inc. REGN|iRhythm Technologies Inc - Enterprise Value|LNTH: Enterprise Value|MLYS: Total Company Value|Heartflow Inc (HTFL) - Enterprise Value|KMTS - Enterprise Value|Value Adjusted for Debt and Cash Esperion Therapeutics, Inc.|Amarin Corp - Enterprise Value|Total Enterprise Value anteristech.com (AVR)|Enterprise Value TNYA (Tenaya Therapeutics, Inc.)|cvrx.com - Enterprise Value|Total Company Value Milestone Pharmaceuticals Inc. (MIST)|Cardiol Therapeutics (CRDL) - Value Adjusted for Debt and Cash|BEAT - Real Price to Acquire Entire Company|Tenax Therapeutics Inc (TENX) - Aggregate Business Value|Enterprise Value ADGM|Real Price to Acquire Entire Company biocardia.com|Enterprise Value ABIO|Enterprise Value acastipharma.com ACST|Real Price to Acquire Entire Company Aerovate (AVTE)|Aggregate Business Value Verve Therapeutics Inc. VERV|Enterprise Value Windtree (WINT)